PBN honors Business Women winners By PBN Staff PROVIDENCE – Providence Business News today held a luncheon to recognize the accomplishments of the 26 women honored over the past year as part of the newspaper’s second annual program recognizing women in the Rhode Island business community. The luncheon this afternoon at the Providence Marriott Downtown on Orms Street ...

Amazing Women Degroot Dr. Anne De Groot and Amazing Women host Deb Ruggiero talk about immunology, immunoinformatics, and diabetes research. The program is split into two segments, each 11 minutes long. (Player requires Flash and JavaScript)

Amazing Women Degroot Dr. Anne De Groot and Amazing Women host Deb Ruggiero talk about immunology, immunoinformatics, and diabetes research. The program is split into two segments, each 11 minutes long. (Player requires Flash and JavaScript)

In early May, Dr. Annie De Groot will be presenting to the NIH/NIAID regarding next generation epitope-driven vaccines: "More Effector Epitopes, Less Heterologous Epitopes, and no T-regitopes?" The presentation will be hosted by David Sacks, PhD, Chief of Intracellular Parasite Biology Section for the National Institute on Allergy and Infectious Diseases.   While whole killed, whole protein, ...

The Providence Business News has chosen Dr. Annie De Groot as this year's receipient of the Overall Career Achievement Award. From the nomination: Dr. De Groot has a vision for Rhode Island; she sees our state as being the leader in biotechnology, an engine in the new knowledge economy, and a model for economic redevelopment to the ...

https://www.projo.com/business/content/BZ_FATHER_DAUGHTER_02-24-09_H5DCTR0_v45.3093601.html PROVIDENCE – The equipment and building are new, but there is something familiar about Annie De Groot’s new digs: her father, who was among her first faculty appointments at the University of Rhode Island. When Annie De Groot, a Brown University professor and the chief executive officer of EpiVax, was given the job of directing ...

https://www.projo.com/business/content/BZ_INFORMATICS_02-24-09_H5DCOE1_v111.308ebf3.html PROVIDENCE –– The University of Rhode Island has hired the founder of one of the state’s best-known biotechnology firms to lead researchers in thedevelopment of vaccines against malaria, AIDS and tuberculosis. Annie S. De Groot, 53, is not leaving EpiVax Inc., the Providence-based company she helped create in 1998, building on software technology she developed ...

https://www.masshightech.com/stories/2009/02/09/daily43-URI-taps-De-Groot-to-head-new-vaccine-research-center.html The University of Rhode Island’s (URI) biotechnology center in Providence is creating an institute to research the prevention and cure of so-called neglected animal and human diseases, which will be led by Annie De Groot, the CEO of biotech EpiVax Inc. The purpose of the new program, called the Institute for Immunology and Informatics, is to ...

EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery December 1, 2008 (Providence, RI)–EpiVax, Inc, a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to optimize delivery of ...

EpiVax was profiled in an article for Xconomy, which lists five "firms to watch" in Rhode Island who have utilized innovative strategies to grow their companies despite an period of economic downturn that has affected both the state and the country. Specifically, the article states that: "EpiVax uses an informatics system developed by founder and CEO Annie De ...

EpiVax was profiled in an article for Xconomy, which lists five "firms to watch" in Rhode Island who have utilized innovative strategies to grow their companies despite an period of economic downturn that has affected both the state and the country. Specifically, the article states that: "EpiVax uses an informatics system developed by founder and CEO Annie De ...

EpiVax, Inc. has been named as a recipient of the Mass High Tech's 8th Annual Tech Citizenship Awards, which honors technology companies that give back more than one-half of 1 percent of annual reveue. Mass High Tech is the publisher of The Journal of New England Technology. This year's awardees will be honored at an event at the ...

October 8, 2008 (Providence, RI)–Dr. Annie De Groot, CEO of EpiVax, is the lead author on an article highlighting key findings about the activation of natural regulatory T cells by IgG Fc–derived peptide, also known as Epi-13 or “Tregitopes.” These findings were published in the October 8 issue of the prestigious Blood, the medical journal ...

https://www.sheshines.org/content/view/432/443/ She addresses healthcare concerns. Dr. Annie De Groot is CEO and founder of EpiVax, Inc.; co-chief editor and founder of Infectious Diseases in Corrections Report; scientific director and founder of GAIA Vaccine Foundation, and interim medical director and founding member of Clinica Esperanza/Hope Clinic. She designs new vaccines for diseases, offers healthcare in Providence and ...

https://www.beloblog.com/ProJo_Blogs/bizblog/2008/09/providencebased-1.html The Montel Williams MS Foundation today announced a grant to Providence-based Epivax, Inc., the first biotech-related company to be awarded a grant from the foundation. Epivax is a privately held company run by Anne Searls DeGroot that is dedicated to the development and implementation of computational immunology tools to benefit the biotechnology industry. The size of ...